Delta One Therapeutics
We hold a patented technology platform potentially capable of achieving complete remissions in Leukemia patients,with no severe side effects
Delta One Therapeutics is a biotechnology startup company focused on developing state-of-the-art personalized treatments targeting cancer and chronic viral diseases. After 5 years of pioneering research, we created a new technology platform that can generate autologous and heterologous cellular immune therapies for clinical applications. The absence of severe associated side effects is our most distinctive and unique feature.